Columbus startup raises $22M to launch wearable bladder control device

“This new capital will jump-start the highly anticipated launch of Vivally, which sets a new standard for (overactive bladder) care," Avation co-founder and CEO Jill Schiaparelli said.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news